McLaughlin M - Search Results

1

Impact of Pruritus on Quality of Life and Current Treatment Patterns in Patients with Primary Biliary Cholangitis.

Mayo MJ, Carey E, Smith HT, Mospan AR, McLaughlin M, Thompson A, Morris HL, Sandefur R, Kim WR, Bowlus C; TARGET-PBC Investigators; Levy C. Mayo MJ, et al. Among authors: mclaughlin m. Dig Dis Sci. 2023 Mar;68(3):995-1005. doi: 10.1007/s10620-022-07581-x. Epub 2022 Jun 15. Dig Dis Sci. 2023. PMID: 35704252 Free PMC article.

2

GLIMMER: A Randomized Phase 2b Dose-Ranging Trial of Linerixibat in Primary Biliary Cholangitis Patients With Pruritus.

Levy C, Kendrick S, Bowlus CL, Tanaka A, Jones D, Kremer AE, Mayo MJ, Haque N, von Maltzahn R, Allinder M, Swift B, McLaughlin MM, Hirschfield GM; GLIMMER Study Group. Levy C, et al. Among authors: mclaughlin mm. Clin Gastroenterol Hepatol. 2023 Jul;21(7):1902-1912.e13. doi: 10.1016/j.cgh.2022.10.032. Epub 2022 Nov 4. Clin Gastroenterol Hepatol. 2023. PMID: 36343847 Free article. Clinical Trial.

3

Cholestatic Pruritus Treatments in Primary Biliary Cholangitis and Primary Sclerosing Cholangitis: A Systematic Literature Review.

Smith HT, de Souza AR, Thompson AH, McLaughlin MM, Dever JJ, Myers JA, Chen JV. Smith HT, et al. Among authors: mclaughlin mm. Dig Dis Sci. 2023 Jun;68(6):2710-2730. doi: 10.1007/s10620-023-07862-z. Epub 2023 Mar 18. Dig Dis Sci. 2023. PMID: 36933112 Free PMC article.

4

Correction to: Impact of Pruritus on Quality of Life and Current Treatment Patterns in Patients with Primary Biliary Cholangitis.

Mayo MJ, Carey E, Smith HT, Mospan AR, McLaughlin M, Thompson A, Morris HL, Sandefur R, Kim WR, Bowlus C; TARGET-PBC Investigators; Levy C. Mayo MJ, et al. Among authors: mclaughlin m. Dig Dis Sci. 2023 Oct;68(10):4064-4065. doi: 10.1007/s10620-023-08050-9. Dig Dis Sci. 2023. PMID: 37555884 Free PMC article. No abstract available.

5

Japanese subgroup analysis of GLIMMER: A global Phase IIb study of linerixibat for the treatment of cholestatic pruritus in patients with primary biliary cholangitis.

Tanaka A, Atsukawa M, Tsuji K, Notsumata K, Suyama A, Ito H, Das S, von Maltzahn R, McLaughlin MM. Tanaka A, et al. Among authors: mclaughlin mm. Hepatol Res. 2023 Jul;53(7):629-640. doi: 10.1111/hepr.13895. Epub 2023 Mar 13. Hepatol Res. 2023. PMID: 36852705

6

Pharmacokinetics and ADME Characterization of Intravenous and Oral [¹⁴C]-Linerixibat in Healthy Male Volunteers.

Zamek-Gliszczynski MJ, Kenworthy D, Bershas DA, Sanghvi M, Pereira AI, Mudunuru J, Crossman L, Pirhalla JL, Thorpe KM, Dennison JMTJ, McLaughlin MM, Allinder M, Swift B, O'Connor-Semmes RL, Young GC. Zamek-Gliszczynski MJ, et al. Among authors: mclaughlin mm. Drug Metab Dispos. 2021 Dec;49(12):1109-1117. doi: 10.1124/dmd.121.000595. Epub 2021 Oct 8. Drug Metab Dispos. 2021. PMID: 34625435 Clinical Trial.

7

Superiority of dutasteride 0.5 mg and tamsulosin 0.2 mg for the treatment of moderate-to-severe benign prostatic hyperplasia in Asian men.

Haque N, Masumori N, Sakamoto S, Ye Z, Yoon SJ, Kuo HC, Brotherton B, Wilson T, Muganurmath C, McLaughlin M, Manyak M. Haque N, et al. Among authors: mclaughlin m. Int J Urol. 2018 Nov;25(11):944-951. doi: 10.1111/iju.13785. Epub 2018 Sep 9. Int J Urol. 2018. PMID: 30198102 Clinical Trial.

8

Examining well-being and cognitive function in people with long Covid and ME/CFS, and age-matched healthy controls: A Case-Case-Control Study.

Sanal-Hayes NEM, Mclaughlin M, Hayes LD, Berry ECJ, Sculthorpe NF. Sanal-Hayes NEM, et al. Among authors: mclaughlin m. Am J Med. 2024 May 13:S0002-9343(24)00273-0. doi: 10.1016/j.amjmed.2024.04.041. Online ahead of print. Am J Med. 2024. PMID: 38750713

9

Ex vivo sensitivity to broadly neutralizing antibodies and anti-CD4 antibody UB-421 of infectious viral isolates from people living with multidrug-resistant HIV.

Rai MA, Blazkova J, Justement JS, Shi V, Kennedy BD, Manning MR, McLaughlin M, Sneller MC, Pau AK, Moir S, Chun TW. Rai MA, et al. Among authors: mclaughlin m. EBioMedicine. 2024 May 9;104:105151. doi: 10.1016/j.ebiom.2024.105151. Online ahead of print. EBioMedicine. 2024. PMID: 38728839 Free article.

10

The Use of Methylphenidate During Inpatient Rehabilitation After Pediatric Traumatic Brain Injury: Population Characteristics and Prescribing Patterns.

Caliendo E, Lowder R, McLaughlin MJ, Watson WD, Baum KT, Blackwell LS, Koterba CH, Hoskinson KR, Tlustos SJ, Shah SA, Suskauer SJ, Kurowski BG. Caliendo E, et al. Among authors: mclaughlin mj. J Head Trauma Rehabil. 2024 May-Jun 01;39(3):E122-E131. doi: 10.1097/HTR.0000000000000889. Epub 2023 Aug 14. J Head Trauma Rehabil. 2024. PMID: 38709832

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,515 results

Search Page